Titan Medical (CVE:TMD) said today its shareholders approved a reverse stock split.
根据新闻稿，股票比率尚未宣布，并将由公司董事会自行决定决定。
Toronto-based Titan Medical added that the range of post-consolidation shares will be a single common share for every 5 to 30 outstanding pre-consolidation common shares, according to a press release.
In April, Titan Medical said itspiked talks with Chinese distributor Longtai Medicalover its Sport robot-assisted surgery platform so it can focus on winning regulatory approvals in the U.S. and Europe.
早在2015年10月，泰坦inked a private placement deal with Longtai中国医疗设备分销商Ningbo Long Hengtai International Trade Co.的子公司，最终价值超过2400万美元。
Filed Under:The Robot Report
Tell Us What You Think!